Dr. Kevin McElfresh, CEO

Dr. McElfresh has operated, managed, and directed forensic DNA laboratories for over twenty years. He did his first forensic DNA case in 1987 using RFLP. He began using STRs in 1993 on a government research and operations project. He is currently founder and CEO of Casework Genetics.

Career Highlights include:

• Director of Identity Testing at Lifecodes Corporation in the 1980s and early 90s.
• Founder and Executive Director of the Bode Technology Group.
• Member of the exhumation and evaluation team for the identification of the remains in the Tomb of the Unknown Soldier at Arlington National Cemetery.
• Is currently a faculty member and an officer of the board of directors of the Virginia Institute of Forensic Science and Medicine.
• Current research is directed at new methods of sample processing and parsing DNA results that are mixtures of multiple individuals.

Education:
Ph.D., 1984 in Molecular and Population Genetics from the University of Georgia
M.Sc., 1982 in Molecular, Cellular and Developmental Biology from Iowa State University.
B.Sc., 1979 in Biological Sciences, from Florida International University.

He is gloriously happy to be back in the lab and preparing to do casework again.

Ron Sosnowski, Ph.D., CSO

Dr. Sosnowski’s formal training includes a doctorate in biochemistry from The John’s Hopkins University and Post-Doctoral instruction at The Johns Hopkins Medical Institutes as a Howard Hughes Fellow. He has focused on analysis of nucleic acids throughout his career. Under that technical umbrella, he has special experience in microelectronic DNA chips, developing DNA technology for human identification and transgenic cell biology. He has lectured internationally in these fields, published many peer-reviewed papers and is an inventor on 12 issued patents, including the invention of a method for detection of STR alleles by hybridization.

As a member of the founding team at Nanogen, he had the opportunity to participate in the development of a biotech company from startup, through IPO and into product launch. This included management of several NIJ and other government grants for the development of novel human DNA identification platforms. He currently holds a position as the Vice President of Research and Development for Adnavance Technologies Inc., developing molecular diagnostic devices for point-of-care applications, using a novel method of electrochemical detection.

As Chief Scientific Officer for Casework Genetics, Dr. Sosnowski is responsible for research and development of new methods and products for human DNA identification.